Oligomers of Aβ peptide are implicated as the most probable causative agent in Alzheimer’s disease. However, their structural properties remain elusive due to the dynamic and heterogeneous character of oligomeric species coexisting in solution. Nevertheless, new approaches, mainly based on mass spectrometry, provide unique access to these different structural forms. Using these methods, we previously showed that the N-terminal, non-amyloidogenic region of Aβ is involved in the network of interactions specifically stabilizing oligomers. In the present study, we identified three histidine residues as active participants in this network. Detailed knowledge of the structural features that are potentially important for oligomer-mediated neurotox...
AbstractPathological folding and oligomer formation of the amyloid β-protein (Aβ) are widely perceiv...
In recent years, small protein oligomers have been implicated in the aetiology of a number of import...
Although most cases of Alzheimer's disease (AD) are sporadic, ∼5% of cases are genetic in origin. Th...
Oligomeric forms of the Aβ peptide represent the most probable neurotoxic agent in Alzheimer’s disea...
Mounting evidence points to the soluble oligomers of amyloid β (Aβ) peptide as important neurotoxic ...
Oligomeric forms of the Aβ peptide represent the most probable neurotoxic agent in Alzheimer's disea...
Oligomers formed by amyloid beta peptide (Aβ) are widely believed to be the main neurotoxic agent in...
Since its discovery, amyloid-β (Aβ) has been the principal target of investigation of in Alzheimer's...
The formation of aggregates of the amyloidogenic peptide β-amyloid (Aβ), termed oligomers, is centra...
Correct folding of proteins is essential for maintaining a functional living cell. Misfolding and ag...
The formation of oligomers of the amyloid-β peptide plays a key role in the onset of Alzheimer's dis...
AbstractThe aggregation of amyloid-β protein (Aβ) in vivo is a critical pathological event in Alzhei...
Oligomeric species populated during the aggregation of the Aβ42 peptide have been identified as pote...
The amyloid-β (Aβ) peptide is associated with the development of Alzheimer’s disease and is known to...
While amyloid plaques and fibrils are a visible hallmark of Alzheimer's disease, smaller assemblies ...
AbstractPathological folding and oligomer formation of the amyloid β-protein (Aβ) are widely perceiv...
In recent years, small protein oligomers have been implicated in the aetiology of a number of import...
Although most cases of Alzheimer's disease (AD) are sporadic, ∼5% of cases are genetic in origin. Th...
Oligomeric forms of the Aβ peptide represent the most probable neurotoxic agent in Alzheimer’s disea...
Mounting evidence points to the soluble oligomers of amyloid β (Aβ) peptide as important neurotoxic ...
Oligomeric forms of the Aβ peptide represent the most probable neurotoxic agent in Alzheimer's disea...
Oligomers formed by amyloid beta peptide (Aβ) are widely believed to be the main neurotoxic agent in...
Since its discovery, amyloid-β (Aβ) has been the principal target of investigation of in Alzheimer's...
The formation of aggregates of the amyloidogenic peptide β-amyloid (Aβ), termed oligomers, is centra...
Correct folding of proteins is essential for maintaining a functional living cell. Misfolding and ag...
The formation of oligomers of the amyloid-β peptide plays a key role in the onset of Alzheimer's dis...
AbstractThe aggregation of amyloid-β protein (Aβ) in vivo is a critical pathological event in Alzhei...
Oligomeric species populated during the aggregation of the Aβ42 peptide have been identified as pote...
The amyloid-β (Aβ) peptide is associated with the development of Alzheimer’s disease and is known to...
While amyloid plaques and fibrils are a visible hallmark of Alzheimer's disease, smaller assemblies ...
AbstractPathological folding and oligomer formation of the amyloid β-protein (Aβ) are widely perceiv...
In recent years, small protein oligomers have been implicated in the aetiology of a number of import...
Although most cases of Alzheimer's disease (AD) are sporadic, ∼5% of cases are genetic in origin. Th...